Gold prices have held steady despite rising bond yields and interest rate expectations, but Bank of America warns these headwinds may soon weigh heavily on gold. The bank maintains a bullish outlook for 2027 but expects prices to fall to around $3,750 per ounce by the fourth quarter of 2023 due to elevated energy prices and ongoing Middle East tensions. Rising oil prices could force central banks to sell gold, adding further pressure. Investment demand remains resilient but is insufficient to support prices near $5,000 an ounce, with the Iran conflict posing a key risk to gold's near-term strength.
Gold prices are forecasted by Bank of America to potentially fall below $4,000 in Q4 2023. For readers following US stocks on Pluang, here is the market snapshot as of Oct 02, 2026 00:02 WIB: out of 150 priced US stocks, 62 rose and 87 fell. Notable movers include SE (Sea Limited) at USD 94.23 with a 1-day change of -3.21%, IQ (IQIYI Inc - ADR) at USD 0.97 down 3.16%, and DIS (Walt Disney Co) at USD 101.73 down 3.03%.
Foghorn Therapeutics saw its price target cut from $12 to $5 after it and Eli Lilly decided not to advance key cancer drug programs. The companies will not continue development of FHD-909 or a selective SMARCA2 degrader, ending their collaboration. F...
RPM International is set to report its Q3 2026 earnings on October 6, with analysts forecasting earnings per share of $1.95 and revenue of $2.22 billion, both higher than the previous year. Despite a slight recent dip in the EPS estimate, the report ...
Jefferies increased its price target for Regeneron to $930, citing an expanded partnership with Sanofi to develop four new long-acting antibodies targeting inflammatory pathways. Sanofi will pay Regeneron $1 billion upfront, with potential milestone ...
McCormick & Company reported fiscal Q3 results with adjusted EPS of $0.86, surpassing estimates of $0.76, and revenue of $2.02 billion, up 17.4% from last year. Growth was driven by the McCormick de Mexico acquisition, pricing actions, and favorable ...
Aehr Test Systems is set to report Q3 earnings of $0.11 per share and revenue around $27 million, marking a 1,000% increase in earnings year-over-year. The company projects fiscal 2027 revenue growth between 160% and 200%, reaching $130-$150 million,...
